RecruitingNot ApplicableNCT04222478

Interest of Auriculotherapy in the Treatment of Xerostomia

Interest of Auriculotherapy in the Treatment of Xerostomia.


Sponsor

Hopital Foch

Enrollment

68 participants

Start Date

Dec 4, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to show that auriculotherapy is effective in the treatment of xerostomia


Eligibility

Min Age: 18 Years

Inclusion Criteria15

  • Patients over 18 years old;
  • Complain about xerostomia after cervical irradiation in the context of ENT cancer;
  • End of radiotherapy> 3 months
  • Covered by a national healthcare insurance
  • Consent form signed.
  • Pregnant or breastfeeding women;
  • Local counterindication to auriculotherapy;
  • With anticoagulant treatment;
  • History or existing of hemophilia;
  • Valvular prosthesis;
  • Ear's pavilion infection;
  • Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months;
  • Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management);
  • Difficulty to comply with the treatment, questionnaires or study protocol;
  • Being deprived of liberty or under guardianship.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSpecific auriculotherapy

3 sessions of auriculotherapy with semi-permanent needles on the 6 points according to the "protocol of Alimi" at one month intervals.

OTHERNon-specific auriculotherapy

3 sessions of auriculotherapy with semi-permanent needles on non-specific points.


Locations(4)

Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan

Brest, Brittany Region, France

Hôpital Forcilles

Férolles-Attilly, France

GHP Saint Joseph

Paris, France

Hôpital Foch

Suresnes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04222478


Related Trials